Covidien plc's Minnesota Unit May Face Cuts After Medtronic, Inc. Deal Is Done
Covidien may be axing jobs but others are hiring too! Check it out! (Isn't it tempting?)
Covidien's Twin Cities-based endovascular business could be an easy target for restructuring following the company's $43 billion sale to Medtronic Inc.
Fridley-based Medtronic (NYSE: MDT) and Covidien are both big players in med-tech, but they don't compete head-to-head in many markets. One area where they do overlap, however, is in the market for endovascular technology. Both companies make devices for treating peripheral artery disease, for instance.
Help employers find you! Check out all the jobs and post your resume.
Covidien's Twin Cities-based endovascular business could be an easy target for restructuring following the company's $43 billion sale to Medtronic Inc.
Fridley-based Medtronic (NYSE: MDT) and Covidien are both big players in med-tech, but they don't compete head-to-head in many markets. One area where they do overlap, however, is in the market for endovascular technology. Both companies make devices for treating peripheral artery disease, for instance.
Help employers find you! Check out all the jobs and post your resume.